02AI

Drug discovery is essential to the world today but is also famous for its difficulty, the average investment for a new drug to go from inception to market is around $2B and the average success rate is less than 10%. This is largely attributed to the vast search space presented to pharma companies. The estimated potential drug like structure is 10^60, so companies cannot screen enough structures to decide which goes to clinical trial and hence a lot of drugs went to the wrong direction in the first place. 02AI is automating and streamlining the R&D stage of drug discovery, the stage where companies use algorithms and data to find the best potential compound structure. Through the 02AI's agentic AI platform, researchers can screen, on average, 10X more structures as they used to, leading to a significantly improved drug discovery success rate.